Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dopesh Raja Mulakala Outcome of Board Meeting
The Board has approved the allotment of 5,84,000 equity shares of Rs. 10/- each at a premium of Rs. 75/- each (Total Issue Price - Rs. 85/- per share) on preferential basis Board Meeting Intimation for Preferential Allotment Of Equity Shares
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/11/2018 ,inter alia, to consider and approve the allotment of equity shares to Promoters and Non Promoters on Preferential basis in accordance with special resolution passed by shareholders in their EGM held on September 29, 2018 Statement Of No Deviation And Variation Under Reg 32 For The Half Year Ended September 30, 2018
Statement of no deviation and variation under Reg 32 for the half year ended September 30, 2018 Outcome Of Board Meeting Held On November 09, 2018
Outcome of Board Meeting held on November 09, 2018 and un-audited financial results for the half year ended September 30, 2018 Board Meeting Intimation for Approval Of Unaudited Financials For The Half Year Ended September 30, 2018
VANTA BIOSCIENCE LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2018 ,inter alia, to consider and approve unaudited financials for the half year ended September 30, 2018 and other matters Shareholding for the Period Ended September 30, 2018
Vanta Bioscience Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Shareholding for the Period Ended September 30, 2018
Vanta Bioscience Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Compliance Certificate Under Reg 7(3) For The Half Year Ended September 30, 2018
Compliance Certificate under Reg 7(3) for the half year ended September 30, 2018